Pioglitazone attenuates progression of aortic valve calcification via down-regulating receptor for advanced glycation end products (Q45721093)

15 December 2017

Pioglitazone attenuates progression of aortic valve calcification via down-regulating receptor for advanced glycation end products (English)

1 reference

15 December 2017

2

1 reference

15 December 2017

Fei Li

1

1 reference

15 December 2017

Fang Chen

3

1 reference

15 December 2017

Xucong Shi

4

1 reference

15 December 2017

Qiao Zhang

5

1 reference

15 December 2017

Si Chen

6

1 reference

15 December 2017

Jiawei Shi

7

1 reference

15 December 2017

Dao Wen Wang

8

1 reference

15 December 2017

Nianguo Dong

9

1 reference

15 December 2017

16 October 2012

1 reference

Basic Research in Cardiology

15 December 2017

1 reference

15 December 2017

107

1 reference

15 December 2017

306

1 reference

15 December 2017

6

1 reference

https://scigraph.springernature.com/pub.10.1007/s00395-012-0306-0

15 December 2017

0 references

cites work

Aortic Msx2-Wnt calcification cascade is regulated by TNF-alpha-dependent signals in diabetic Ldlr-/- mice.

1 reference

https://api.crossref.org/works/10.1007%2FS00395-012-0306-0

Circulating soluble receptor for advanced glycation end-product levels are decreased in patients with calcific aortic valve stenosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-012-0306-0

Pioglitazone limits myocardial infarct size, activates Akt, and upregulates cPLA2 and COX-2 in a PPAR-γ-independent manner.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-012-0306-0

2008 Focused update incorporated into the ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Commit

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-012-0306-0

Effect of insulin on the differential expression of VLDL receptor isoforms of SGC7901 cell and its biological implication.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-012-0306-0

Arterial calcification is driven by RAGE in Enpp1-/- mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-012-0306-0

RAGE (receptor for advanced glycation end products): a central player in the inflammatory response

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-012-0306-0

Experimental aortic valve stenosis in rabbits

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-012-0306-0

Risk of death and cardiovascular outcomes with thiazolidinediones: a study with the general practice research database and secondary care data

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-012-0306-0

Double-blind, randomized, multicentre, and active comparator controlled investigation of the effect of pioglitazone, metformin, and the combination of both on cardiovascular risk in patients with type 2 diabetes receiving stable basal insulin therap

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-012-0306-0

Vascular and inflammatory stresses mediate atherosclerosis via RAGE and its ligands in apoE-/- mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-012-0306-0

Induction of local angiotensin II-producing systems in stenotic aortic valves.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-012-0306-0

Thiazolidinediones and risk of heart failure in patients with or at high risk of type 2 diabetes mellitus: a meta-analysis and meta-regression analysis of placebo-controlled randomized clinical trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-012-0306-0

S100A12 in vascular smooth muscle accelerates vascular calcification in apolipoprotein E-null mice by activating an osteogenic gene regulatory program

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-012-0306-0

Peroxisome proliferator-activated receptor gamma: implications for cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-012-0306-0

Peroxisome proliferator-activated receptor-gamma activation attenuates cardiac fibrosis in type 2 diabetic rats: the effect of rosiglitazone on myocardial expression of receptor for advanced glycation end products and of connective tissue growth fac

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-012-0306-0

Porcine cardiac valvular subendothelial cells in culture: cell isolation and growth characteristics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-012-0306-0

Pioglitazone inhibits in-stent restenosis in atherosclerotic rabbits by targeting transforming growth factor-beta and MCP-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-012-0306-0

Interleukin-1 beta promotes matrix metalloproteinase expression and cell proliferation in calcific aortic valve stenosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-012-0306-0

Relationship of metabolic syndrome with incident aortic valve calcium and aortic valve calcium progression: the Multi-Ethnic Study of Atherosclerosis (MESA).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-012-0306-0

Oxidant generation predominates around calcifying foci and enhances progression of aortic valve calcification

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-012-0306-0

RAGE signaling in inflammation and arterial aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-012-0306-0

Comparative cardiovascular effects of thiazolidinediones: systematic review and meta-analysis of observational studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-012-0306-0

The antioxidant N-acetylcysteine promotes atherosclerotic plaque stabilization through suppression of RAGE, MMPs and NF-κB in ApoE-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-012-0306-0

Crosstalk between the canonical NF-κB and Notch signaling pathways inhibits Pparγ expression and promotes pancreatic cancer progression in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-012-0306-0

Thiazolidinediones reduce endothelial expression of receptors for advanced glycation end products

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-012-0306-0

Upregulation of the 5-lipoxygenase pathway in human aortic valves correlates with severity of stenosis and leads to leukotriene-induced effects on valvular myofibroblasts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-012-0306-0

Pathogenesis of calcific aortic valve disease: a disease process comes of age (and a good deal more).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-012-0306-0

Accumulation of T lymphocytes and expression of interleukin-2 receptors in nonrheumatic stenotic aortic valves

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-012-0306-0

Expression and regulation of Runx2/Cbfa1 and osteoblast phenotypic markers during the growth and differentiation of human osteoblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-012-0306-0

Calcific aortic valve disease: not simply a degenerative process: A review and agenda for research from the National Heart and Lung and Blood Institute Aortic Stenosis Working Group. Executive summary: Calcific aortic valve disease-2011 update.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-012-0306-0

The peroxisome proliferator-activated receptor-gamma is a negative regulator of macrophage activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-012-0306-0

Receptor for advanced glycation end products (RAGE) deficiency attenuates the development of atherosclerosis in diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-012-0306-0

Recombinant apolipoprotein A-I Milano rapidly reverses aortic valve stenosis and decreases leaflet inflammation in an experimental rabbit model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-012-0306-0

RAGE mediates oxidized LDL-induced pro-inflammatory effects and atherosclerosis in non-diabetic LDL receptor-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-012-0306-0

Advanced glycation end products induce calcification of vascular smooth muscle cells through RAGE/p38 MAPK.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-012-0306-0

S100A8/A9 aggravates post-ischemic heart failure through activation of RAGE-dependent NF-κB signaling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-012-0306-0

HMGB1: the missing link between diabetes mellitus and heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-012-0306-0

Peroxisome proliferator-activated receptor gamma down-regulates receptor for advanced glycation end products and inhibits smooth muscle cell proliferation in a diabetic and nondiabetic rat carotid artery injury model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-012-0306-0

The potential effects of anti-diabetic medications on myocardial ischemia-reperfusion injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00395-012-0306-0

10.1007/S00395-012-0306-0

21 January 2018

Identifiers

DOI

1 reference

Dimensions Publication ID

15 December 2017

0 references

1 reference